Research
Evidence, read off the primary source.
No pattern-matched citations and no PMIDs pulled from memory. Every regulatory date, study, and label quote below was fetched live and checked against its primary source before publication — see each article's reference list.
How we verify a source
A PubMed citation is checked against PubMed's own record, not typed from recall. A regulatory page is fetched live and quoted, not paraphrased from a secondary blog. If a claim cannot be verified this way, it is softened or removed — never guessed.
Evidence review
Retatrutide: What's Actually Approved, What's Actually Known, and What It Actually Costs Right Now
Retatrutide is investigational, not FDA-approved. What its trial data shows, and why searching its cost leads to something riskier than most coverage admits.
ReadEvidence review
Sermorelin vs. Ipamorelin vs. CJC-1295: What the Evidence on Growth-Hormone Secretagogues Actually Shows
Sermorelin and CJC-1295 share a receptor; ipamorelin uses another. None is FDA-approved for what telehealth sells, and all three are banned in tested sport.
ReadEvidence review
Is Compounded Tirzepatide Still Legal? What the FDA Actually Says
The FDA declared the tirzepatide shortage resolved in 2024. Here is what that actually changed for compounding pharmacies, read off the agency's own timeline.
Read